Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 85 of 1714:
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95
Gene Compound Assay Inh Ic50 Ki View
phosphodiesterase 4A, cAMP specific RWJ-68354 Phosphodiesterase PDE4 59% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific RWJ-68354 Phosphodiesterase PDE4 59% NoneNone NoneNone View
phosphodiesterase 4D RWJ-68354 Phosphodiesterase PDE4 59% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific RWJ-68354 Phosphodiesterase PDE4 59% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) RWJ-68354 Protein Tyrosine Kinase, HER2 Receptor 59% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) RWJ-68354 Protein Tyrosine Kinase, HER2 Receptor 59% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) MITOXANTRONE Protein Tyrosine Kinase, Lck 59% NoneNone NoneNone View
mitogen activated protein kinase 14 ZIRCONIUM(IV) CHLORIDE Protein Serine/Threonine Kinase, p38alpha 59% NoneNone NoneNone View
mitogen-activated protein kinase 14 ZIRCONIUM(IV) CHLORIDE Protein Serine/Threonine Kinase, p38alpha 59% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B QUINACRINE Serotonin 5-HT1B 59% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A SELEGILINE Serotonin 5-HT2A 59% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) SELEGILINE Adrenergic alpha1D 59% NoneNone NoneNone View
adrenergic receptor, alpha 1a ONDANSETRON Adrenergic alpha1A 59% NoneNone NoneNone View
mitogen activated protein kinase 1 EPALRESTAT Protein Serine/Threonine Kinase, ERK2 59% NoneNone NoneNone View
mitogen-activated protein kinase 1 EPALRESTAT Protein Serine/Threonine Kinase, ERK2 59% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase TACRINE CYP450-1A2 Inhibition 59% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific CADMIUM CHLORIDE Phosphodiesterase PDE5 59% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific CADMIUM CHLORIDE Phosphodiesterase PDE5 59% NoneNone NoneNone View
adrenergic receptor, beta 3 ZAFIRLUKAST Adrenergic beta3 59% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
sodium channel associated protein 1 PHENTOLAMINE Sodium Channel, Site 2 59% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase CLOBETASOL PROPIONATE CYP450-2C19 Inhibition 59% NoneNone NoneNone View
Sigma-2 Receptor KETOCONAZOLE Sigma2 59% 15.913uM 9.793uM View
adrenergic receptor, alpha 2b DANAZOL Adrenergic alpha2B 59% 23.163uM 10.574uM View
opioid receptor, sigma 1 MIFEPRISTONE Sigma1 59% 26.28uM 11.047uM View
Cytochrom P450-1A2 monooxygenase FLUTAMIDE CYP450-1A2 Inhibition 59% NoneNone NoneNone View
epidermal growth factor receptor 4-OCTYLPHENOL Protein Tyrosine Kinase, EGF Receptor 59% 16.219uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 4-OCTYLPHENOL Adrenergic, Norepinephrine Transporter 59% 61.647uM 61.138uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 BISPHENOL A Dopamine Transporter 59% 19.015uM 15.108uM View
histamine receptor H 2 RANITIDINE Histamine H2 59% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 TANNIC ACID Adenosine Transporter 59% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) TANNIC ACID Adenosine Transporter 59% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 TANNIC ACID Adenosine Transporter 59% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) TANNIC ACID Adenosine Transporter 59% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 TANNIC ACID Adenosine Transporter 59% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A AMOXAPINE Serotonin 5-HT1A 59% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 U-78517F Dopamine Transporter 59% 13.352uM 10.609uM View
A3 adenosine receptor U-78517F Adenosine A3 59% 10.75uM 6.077uM View
dopamine receptor 2 U-78517F Dopamine D2L 59% 16.76uM 5.587uM View
5-hydroxytryptamine (serotonin) receptor 1B CLOTRIMAZOLE Serotonin 5-HT1B 59% 27.31uM 12.413uM View
Sigma-2 Receptor CHLORPROMAZINE Sigma2 59% 2.718uM 1.673uM View
melanocortin 4 receptor TAMOXIFEN Melanocortin MC4 59% 30.481uM 29.308uM View
adrenergic receptor, alpha 1b BRIMONIDINE Adrenergic alpha1B 59% NoneNone NoneNone View
mu-opioid receptor MOR CARVEDILOL Opiate mu 59% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A THIMEROSAL Serotonin 5-HT1A 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, gamma subunit 4 FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, gamma subunit 3 FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, gamma subunit 2 FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, gamma subunit 1 FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, beta 4 subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, beta 3 subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, beta 2 subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, alpha 1F subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
carbonic anhydrase VI ISONIAZID Carbonic Anhydrase 9% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, beta 1 subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 FLUPHENAZINE Calcium Channel Type L, Dihydropyridine 59% 29.304uM 18.838uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit METHAPYRILENE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 METHAPYRILENE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 HYDROXYCHLOROQUINE Calcium Channel Type L, Phenylalkylamine 59% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) OXYBUTYNIN CYP450-2C9 Inhibition 59% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 OXYBUTYNIN CYP450-2C9 Inhibition 59% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase ARTEMISININ CYP450-2C19 Inhibition 59% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase ALPHA-ERGOCRYPTINE CYP450-2C19 Inhibition 59% NoneNone NoneNone View
Sigma-2 Receptor MAPROTILINE Sigma2 59% NoneNone NoneNone View
opioid receptor, sigma 1 SPIRADOLINE Sigma1 59% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TERCONAZOLE Adrenergic, Norepinephrine Transporter 59% 25.391uM 25.182uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PINDOLOL Dopamine Transporter 59% NoneNone NoneNone View
progesterone receptor GW-1929 Progesterone 59% 30.622uM 3.994uM View
progesterone receptor GW-1929 Progesterone 59% 30.622uM 3.994uM View
phosphodiesterase 3B GW-1929 Phosphodiesterase PDE3 59% 19.36uM NoneNone View
phosphodiesterase 3A GW-1929 Phosphodiesterase PDE3 59% 19.36uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B METOCLOPRAMIDE Serotonin 5-HT4 59% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 METOCLOPRAMIDE Serotonin 5-HT4 59% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CYPROHEPTADINE Dopamine Transporter 59% NoneNone NoneNone View
adrenergic receptor, beta 2 ESMOLOL Adrenergic beta2 58% NoneNone NoneNone View
adrenergic receptor, alpha 1b HOMATROPINE HYDROBROMIDE Adrenergic alpha1B 58% NoneNone NoneNone View
monoamine oxidase A DISULFIRAM Monoamine Oxidase MAOA 58% 13.734uM NoneNone View
monoamine oxidase A DISULFIRAM Monoamine Oxidase MAOA 58% 13.734uM NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 RISPERIDONE Serotonin Transporter 58% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 L-744832 Muscarinic M1 58% NoneNone NoneNone View
adrenergic receptor, alpha 1b SELEGILINE Adrenergic alpha1B 58% NoneNone NoneNone View
opioid receptor, sigma 1 SELEGILINE Sigma1 58% NoneNone NoneNone View
adrenergic receptor, beta 2 NORTRIPTYLINE Adrenergic beta2 58% NoneNone NoneNone View
dopamine receptor 2 NORTRIPTYLINE Dopamine D2L 58% NoneNone NoneNone View
androgen receptor NIMODIPINE Testosterone 58% NoneNone NoneNone View
adrenergic receptor, alpha 1b ONDANSETRON Adrenergic alpha1B 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PRIMAQUINE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A RALOXIFENE Serotonin 5-HT1A 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PHENTOLAMINE Calcium Channel Type L, Benzothiazepine 58% NoneNone NoneNone View
epidermal growth factor receptor RALOXIFENE Protein Tyrosine Kinase, EGF Receptor 58% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase NISOLDIPINE CYP450-2C19 Inhibition 58% NoneNone NoneNone View
A3 adenosine receptor BAY 11-7085 Adenosine A3 58% NoneNone NoneNone View
matrix metallopeptidase 9 NISOLDIPINE Protease, Matrix Metalloprotease-9 (MMP-9) 58% NoneNone NoneNone View
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) NISOLDIPINE Protease, Matrix Metalloprotease-9 (MMP-9) 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 ITRACONAZOLE Calcium Channel Type L, Phenylalkylamine 58% NoneNone NoneNone View